United States · FDA National Drug Code directory

Low Virus Nosode 4023

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 63083-4023_4dcb4518-ea81-46cc-8930-0fefd599fb8f
Product NDC: 63083-4023
Form: LIQUID
Composition / generic term: Low Virus Nosode
Labeler: Professional Complementary Health Formulas
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start / end (source format): 19840815
Source listing expiry: 20271231

Source-listed ingredients

COXSACKIEVIRUS A21 — 12 [hp_X]/59mL
HUMAN HERPESVIRUS 5 — 12 [hp_X]/59mL
HUMAN HERPESVIRUS 4 — 12 [hp_X]/59mL
HAEMOPHILUS INFLUENZAE — 12 [hp_X]/59mL
DALEA FOLIOLOSA WHOLE — 12 [hp_X]/59mL
DRABA VERNA WHOLE — 12 [hp_X]/59mL
JUSTICIA SPICIGERA LEAF — 12 [hp_X]/59mL
VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF HEALTH LIVE ANTIGEN — 12 [hp_X]/59mL
HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN — 12 [hp_X]/59mL
BACILLUS CALMETTE-GUERIN LIVE ANTIGEN, UNSPECIFIED SUBSTRAIN — 30 [hp_X]/59mL
POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED) — 30 [hp_X]/59mL

These values do not establish equivalence or a dose recommendation.

Packages

59 mL in 1 BOTTLE, DROPPER (63083-4023-2) · 63083-4023-2

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →